Skip to main content
. Author manuscript; available in PMC: 2022 May 13.
Published in final edited form as: Lancet Glob Health. 2022 Apr;10(4):e555–e563. doi: 10.1016/S2214-109X(22)00030-4

Table 2:

The iBreastExam and clinical breast examination sensitivity, specificity, NPV, and PPV

True positive False negative True negative False positive Sensitivity (95% CI) Specificity (95% CI) NPV (95% CI) PPV (95%CI)
Any breast finding
The iBreastExam 147 86 110 76 63% (57–69) 59% (52–66) 56% (49–63) 66% (59–72)
Clinical breast examination 71 162 175 11 31% (25–37) 94% (90–97) 52% (46–57) 87% (77–93)
p value ·· ·· ·· ·· <0·0001 <0·0001 0·080 <0·0001
Suspicious breast finding
The iBreastExam 31 5 191 192 86% (70–95) 50% (45–55) 98% (94–99) 14% (10–19)
Clinical breast examination 30 6 331 52 83% (67–94) 86% (83–90) 98% (96–99) 37% (26–48)
p value ·· ·· ·· ·· 0·65 <0·0001 0·42 0·0020

Findings were determined by breast imaging (n=419). NPV=negative predictive value. PPV=positive predictive value.